0001209191-19-061842.txt : 20191223
0001209191-19-061842.hdr.sgml : 20191223
20191223193401
ACCESSION NUMBER: 0001209191-19-061842
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191220
FILED AS OF DATE: 20191223
DATE AS OF CHANGE: 20191223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cappel Markus J.
CENTRAL INDEX KEY: 0001422995
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 191307781
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-20
0
0001340652
ChemoCentryx, Inc.
CCXI
0001422995
Cappel Markus J.
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW
CA
94043
0
1
0
0
Chief Bus. Officer & Treasurer
Common Stock
2019-12-20
4
M
0
3544
7.10
A
38985
D
Common Stock
2019-12-20
4
M
0
12369
8.19
A
51354
D
Common Stock
2019-12-20
4
M
0
12000
3.57
A
63354
D
Common Stock
2019-12-20
4
M
0
2346
6.62
A
65700
D
Stock Option (right to buy)
7.10
2019-12-20
4
M
0
3544
D
2024-02-19
Common Stock
3544
166456
D
Stock Option (right to buy)
8.19
2019-12-20
4
M
0
12369
D
2025-02-23
Common Stock
12369
142631
D
Stock Option (right to buy)
3.57
2019-12-20
4
M
0
12000
D
2026-03-07
Common Stock
12000
53000
D
Stock Option (right to buy)
6.62
2019-12-20
4
M
0
2346
D
2027-02-28
Common Stock
2346
87654
D
As of December 20, 2019, and prior to this transaction, the exercised options were fully vested.
Not applicable.
/s/ Susan M. Kanaya, as Attorney-in-Fact
2019-12-23